312 related articles for article (PubMed ID: 34474337)
1. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
3. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia.
Ye X; Lin ZJ; Hong GH; Wang ZM; Dou RT; Lin JY; Xie JH; Shen YW
Exp Cell Res; 2024 May; 438(2):114061. PubMed ID: 38692345
[TBL] [Abstract][Full Text] [Related]
4. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
5. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
Zeng W; Wu D; Sun Y; Suo Y; Yu Q; Zeng M; Gao Q; Yu B; Jiang X; Wang Y
Sci Rep; 2021 Sep; 11(1):19305. PubMed ID: 34588488
[TBL] [Abstract][Full Text] [Related]
6. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
7. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
9. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
10. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.
Li D; Li C; Wang T; Zhang C; Zhu Z; Zhang G; Fang B
Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204
[TBL] [Abstract][Full Text] [Related]
11. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
[TBL] [Abstract][Full Text] [Related]
12. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
[TBL] [Abstract][Full Text] [Related]
13. Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy.
Ge K; Wang Y; Li P; Li M; Zhang W; Dan H; Hu X; Zhou J; Yang Q; Wang J; Song Z
Microvasc Res; 2022 Jan; 139():104265. PubMed ID: 34662588
[TBL] [Abstract][Full Text] [Related]
14. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
Qu J; Yuan Z; Wang G; Wang X; Li K
Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
[TBL] [Abstract][Full Text] [Related]
15. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell pyroptosis via NLRP3-dependent pathway.
He D; Zhou M; Bai Z; Wen Y; Shen J; Hu Z
Biochem Biophys Res Commun; 2020 Jun; 526(3):772-779. PubMed ID: 32265028
[TBL] [Abstract][Full Text] [Related]
16. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
17. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
[TBL] [Abstract][Full Text] [Related]
18. Chinese medicinal formula Fu Xin decoction against chronic heart failure by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway.
Zhang L; Li Y; Fan CD; Jiang YH; Sheng LS; Song XY; Lin YX; Xue YT; Sun R
Biomed Pharmacother; 2024 May; 174():116548. PubMed ID: 38599064
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of combination of anakinra and MCC950 against acute lung injury is achieved through suppression of the NF-κB-mediated-MAPK and NLRP3-caspase pathways.
Wang X; Chen S; Zhao L; Shi X
Int Immunopharmacol; 2021 Aug; 97():107506. PubMed ID: 34022766
[TBL] [Abstract][Full Text] [Related]
20. NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke.
Bellut M; Papp L; Bieber M; Kraft P; Stoll G; Schuhmann MK
Cell Death Dis; 2021 Dec; 13(1):20. PubMed ID: 34930895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
